Novel biomarkers required to triage and monitor severely ill COVID-19 patients

[News]

Diagnostics company SphingoTec GmbH ("sphingotec") announced today the results of a working group meeting of clinical experts that discussed the utility of sphingotec's diagnostic solutions for acute and critical care in supporting the triage, diagnosis, and management of severely ill COVID-19 patients.

More... (https://www.news-medical.net/news/20200618/Novel-biomarkers-required-to-triage-and-monitor-severely-ill-COVID-19-patients.aspx)